Sign up for our daily briefing
Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.
Stay on top of the latest market trends
Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.
Sports news worthy of your time
Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.
Tech news worthy of your time
Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.
Get the inside stories
Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Catch up on coronavirus stories and special reports, curated by Mike Allen everyday
Want a daily digest of the top Denver news?
Get a daily digest of the most important stories affecting your hometown with Axios Denver
Want a daily digest of the top Des Moines news?
Get a daily digest of the most important stories affecting your hometown with Axios Des Moines
Want a daily digest of the top Twin Cities news?
Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities
Want a daily digest of the top Tampa Bay news?
Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay
Want a daily digest of the top Charlotte news?
Get a daily digest of the most important stories affecting your hometown with Axios Charlotte
Illustration: Annelise Capossela/Axios
A bipartisan commission is recommending an "Apollo Program" to enhance U.S. biodefense — including against engineered viruses.
Why it matters: COVID-19, which will cost millions of lives and trillions of dollars, shuts the door on any argument that new diseases aren't a major global threat. But as biotechnology improves, we especially need ways to detect and deter pathogens designed by human beings, not just by nature.
Driving the news: On Tuesday, the Bipartisan Commission on Biodefense released a set of recommendations outlining how the U.S. could end pandemic threats — both natural and man-made — by 2030.
- The commission — which is co-chaired by former Sen. Joe Lieberman and former Homeland Security Secretary Tom Ridge — argues for spending up to $10 billion a year to speed up vaccine prototypes, enhance genomic sequencing capabilities, and create a national public health data system, among other recommendations.
Details: The report's conclusions are solid, and they're bolstered by the fact that the commission made much the same argument in 2015, years before COVID-19. But I was particularly interested to see the attention paid to the threat of man-made pathogens.
- The report noted that "advances in biotechnology have also made it easier to obtain or modify these pathogens, creating the possibility of pandemics emerging from deliberate attacks or laboratory accidents."
- The commission focused on the need to develop techniques to "distinguish natural and engineered DNA and to inform attribution" of any new pathogens.
What's next: In a recent competition, hundreds of teams around the world developed algorithms designed to predict the origin of genetically engineered DNA sequences.
- The best teams were able to predict the source lab of an unfamiliar engineered DNA sequence over 95% of the time, an improvement over the top previous results.
- Such algorithms can be useful for regulating genetic engineering by ensuring that any edited sequences can be tied back to their point of origin.
- But none of the algorithms would be able to determine for sure whether an unknown DNA sequence was natural or engineered, notes Lane Warmbrod, a senior analyst at the Johns Hopkins Center for Health Security.
The bottom line: We can't stumble blindly into a world where DNA can be engineered like computer code.